China’s growing capabilities have drawn pharmaceutical multinationals to the country to either buy or co-develop innovative ...
In this week’s edition of InnovationRx, we look at the Forbes 30 Under 30 Healthcare list, the coming barriers to getting ...
Weight-loss drug Mounjaro not value for money at current prices for public patients, finds HSE study
A new study for the HSE has found that making the weight loss drug Mounjaro available to public patients would not be value ...
Scientists are testing whether GLP-1 drugs can help to cut cravings for cigarettes, alcohol and opioids — as well as food.
Previous mega blockbusters took years to reach their peak sales. Lilly’s tirzepatide franchise is on course to exceed them ...
MedPage Today on MSN
Medicare Prices to Drop Up to 85% on Drugs for Weight-Loss, Cancer, Asthma, and More
The negotiated prices are a result of a program passed by Congress in 2022 as part of the Inflation Reduction Act (IRA). The ...
Manufacturers may prioritize developing drugs for rare diseases first, delaying negotiations for common condition treatments. A provision in the One Big Beautiful Bill delays or exempts high-spending ...
(AP) Unlike scores of people who scrambled for the blockbuster drugs Ozempic and Wegovy to lose weight in recent years, Danielle Griffin had no trouble getting them. The 38-year-old information ...
Bayer AG said an experimental stroke-prevention drug showed positive results in a late-stage clinical study, a boost for the ...
Some experts cited the case of Slentrol, an older weight loss drug for dogs made by Pfizer’s animal health division (which ...
How the influx of generics is bad for drug makers but good for you. July 25, 2011— -- intro: Ten of the world's top-selling prescription drugs are about to get cheaper. Over the next 17 months, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results